Trials / Sponsors / James Isaacs, MD
James Isaacs, MD
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IIID Melanoma | Phase 1 | 2024-12-02 |